Fosfomycin (FOM: 1R-2S-epoxypropylphosphonic acid) suppress the production of IL-8 from monocytes via the suppression of neutrophil function
Authors:
- 1 May 1998
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 39 (2) , 149-155
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Erythromycin Inhibition of Lipopolysaccharide-Stimulated Tumor Necrosis Factor Alpha Production by Human Monocytes in VitroAnnals of Otology, Rhinology & Laryngology, 1992
- Suppression of pulmonary granulomatous inflammation by immunomodulating agentsInflammation Research, 1992
- Differential modulation of cytokine production by macrolides: interleukin-6 production is increased by spiramycin and erythromycinAntimicrobial Agents and Chemotherapy, 1991
- Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide-stimulated human monocytes to produce IL-1, IL-6 and tumour necrosis factor-alphaClinical and Experimental Immunology, 1991
- Quinolone-induced differential modification of IL-1α and IL-1β production by LPS-stimulated human monocytesCellular Immunology, 1990
- Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activityInfection, 1990
- Effects of quinolones on tumor necrosis factor production by human monocytesInternational Journal of Immunopharmacology, 1990
- Effect of Antibiotics on Immediate Hypersensitivity Reactions in vitro: Suppression of IgE‐Mediated Histamine Release from Peripheral Blood Basophils by FosfomycinMicrobiology and Immunology, 1987
- Mode of protective action of fosfomycin against dibekacin-induced nephrotoxicity in the dehydrated rats.Journal of Pharmacobio-Dynamics, 1982
- THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN)Annals of the New York Academy of Sciences, 1974